Viewing Study NCT05039632


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2026-01-01 @ 11:07 PM
Study NCT ID: NCT05039632
Status: RECRUITING
Last Update Posted: 2025-11-06
First Post: 2021-09-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
Sponsor: M.D. Anderson Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2020-0618
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View